Agustin Albillos

Professor of Medicine

Universidad de Alcalá

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Agustin Albillos is a Professor of Medicine at Universidad de Alcalá in Spain. His research primarily focuses on hepatology, with recent articles exploring the management of portal hypertension, the use of non-selective beta-blockers in cirrhosis, and the impact of genetic factors on COVID-19 severity. He is involved in developing algorithms for patient treatment strategies and employing metabolomics to predict liver-related outcomes.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (8)

Xavier Farré Ramon

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

SPAIN

View details

Pierre‐Emmanuel Rautou

FRANCE

View details

Antonio Julià Cano

Lab head

Vall d'Hebron Institut de Recerca

SPAIN

View details

Ferran Torres

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Rosanna Asselta

Full Professor in Medical Genetics

Humanitas University

ITALY

View details

Cristina Alonso

Services Manager & Head of the Data Processing Department

Rubió Metabolomics

SPAIN

View details

Jaime Bosch

Emeritus Professor of Medicine

University of Barcelona

SPAIN

View details

Mattias Mandorfer

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Agustin Albillos

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis

Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: a post-hoc analysis of the PREDESCI trial

La especialidad de aparato digestivo. Historia. Desarrollo nacional y competencias del especialista. Perspectiva futura

Quantifying the benefit of non-selective beta-blockers in the prevention of hepatic decompensation:

Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis

Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19.

Reply to: “Anticoagulation to prevent disease progression in patients with cirrhosis”

Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

Beta-blockers in the era of precision medicine in patients with cirrhosis

Reply to: “Potential novel approaches to prevent the risk of infection in patients with variceal bleeding”

Collaborators (8)

Xavier Farré Ramon

Pierre‐Emmanuel Rautou

Antonio Julià Cano

Ferran Torres

Rosanna Asselta

Cristina Alonso

Jaime Bosch

Mattias Mandorfer

Make your next move.